Product image of Metypred (Methylprednisolone) supplied by GNH India

Metypred

Active Ingredient:
Methylprednisolone
Origin:
EU

Metypred (Methylprednisolone)

Methylprednisolone, the active ingredient in Metypred, is a glucocorticoid presented as an oral tablet for systemic use. It is employed to treat inflammatory and autoimmune disorders in adults and children when prescribed by a healthcare professional.

GNH India supplies Metypred as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metypred is a glucocorticoid that modulates inflammatory and immune pathways across several disease groups.

  • Rheumatoid arthritis: reduces joint inflammation, pain, and swelling.
  • Systemic lupus erythematosus: suppresses systemic immune activity and organ inflammation.
  • Severe asthma: decreases airway inflammation and improves breathing.
  • Allergic reactions: mitigates severe hypersensitivity symptoms.
  • Dermatologic inflammatory conditions: alleviates skin inflammation such as eczema or psoriasis.
  • Multiple sclerosis exacerbations: shortens relapse duration and severity.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and alters gene transcription. This action up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, thereby suppressing immune cell activation and reducing inflammatory mediator release.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Increased appetite or weight gain.
  • Elevated blood glucose levels.
  • Mood changes, including anxiety or insomnia.
  • Gastrointestinal discomfort or ulcer risk.
  • Fluid retention causing swelling.
  • Mild skin thinning or bruising.

Serious or Rare Side Effects

  • Severe infections or opportunistic pathogens.
  • Adrenal insufficiency on abrupt discontinuation.
  • Osteonecrosis of the hip or jaw.
  • Vision problems such as cataracts or glaucoma.
  • Severe psychiatric disturbances, including psychosis.
  • Thromboembolic events.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess infection risk: evaluate for active infections and vaccinate appropriately.
  • Monitor glucose: check blood sugar in diabetic or at‑risk patients.
  • Screen bone health: consider calcium/vitamin D supplementation and bone density testing.
  • Review psychiatric history: observe for mood or psychotic changes.
  • Evaluate cardiovascular status: monitor blood pressure and fluid balance.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Methylprednisolone may interact with several drug classes; vigilance is required.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase systemic exposure.
  • Live vaccines: risk of uncontrolled infection due to immunosuppression.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened gastrointestinal ulcer risk.
  • Anticoagulants (warfarin): potential for enhanced anticoagulant effect.
  • Diabetic agents (insulin, oral hypoglycemics): may require dose adjustment due to hyperglycemia.
  • Antihypertensives: possible reduction in blood pressure‑lowering efficacy.

Frequently Asked Questions

Metypred (methylprednisolone) is prescribed for inflammatory and autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, severe asthma, allergic reactions, certain skin inflammatory diseases, and multiple sclerosis exacerbations. It works by suppressing immune activity and reducing inflammation.

Methylprednisolone binds to glucocorticoid receptors inside cells, forming a complex that moves into the nucleus and modifies gene expression. This leads to increased production of anti‑inflammatory proteins and decreased synthesis of pro‑inflammatory cytokines, thereby dampening immune responses and inflammation.

The dosage of Metypred is individualized by the prescribing clinician based on the specific condition, severity, patient weight, and response to therapy. Patients should follow the exact regimen provided by their healthcare professional and not adjust the dose on their own.

Safety data for methylprednisolone in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant. Physicians will evaluate the risk‑benefit profile before prescribing to pregnant or nursing women.

To request Metypred, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metypred (methylprednisolone) is a potent intermediate‑acting glucocorticoid. Compared with lower‑potency agents like prednisone, it often provides stronger anti‑inflammatory effects at lower doses, while having a similar safety profile. Choice of corticosteroid depends on disease severity, required potency, and clinician preference.

Metypred tablets should be stored at ambient temperature below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources to maintain product stability.

Metypred is taken orally, usually with a glass of water. The tablet should be swallowed whole unless the prescriber advises otherwise. Dosing frequency (once daily, multiple times daily) and duration are determined by the treating physician.

Serious risks include severe infections, adrenal insufficiency if the drug is stopped abruptly, osteoporosis or bone fractures, hyperglycemia leading to diabetes, and psychiatric effects such as mood swings or psychosis. Patients should be monitored regularly for these complications.

Metypred is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, systemic fungal infections, and those receiving live vaccines. Caution is also advised for individuals with uncontrolled infections, severe hypertension, or existing peptic ulcer disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT